S. Dagogo-Jack

发表

DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes

Angelo J. Canty, J. Keith Jones, A. Paterson, 2020, Clinical Epigenetics.

Recruitment strategies and yields for the Pathobiology of Prediabetes in a Biracial Cohort: a prospective natural history study of incident dysglycemia

S. Dagogo-Jack, Sotonte Ebenibo, Chimaroke Edeoga, 2013, BMC Medical Research Methodology.

Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

R. Vigersky, P. Cryer, E. Seaquist, 2013, Diabetes Care.

Comorbidities of Diabetes and Hypertension: Mechanisms and Approach to Target Organ Protection

S. Dagogo-Jack, A. Long, 2011, Journal of clinical hypertension.

Plasma Leptin and Insulin Relationships in Obese and Nonobese Humans

C. Fanelli, S. Dagogo-Jack, D. Paramore, 1996, Diabetes.

Durable reversal of hypoglycemia unawareness in type 1 diabetes.

P. Cryer, C. Fanelli, S. Dagogo-Jack, 1999, Diabetes care.

Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.

Simon R. Heller, Robert Vigersky, R. Vigersky, 2013, The Journal of clinical endocrinology and metabolism.

Therapy Insight: metabolic and endocrine disorders in sickle cell disease

G. Umpierrez, S. Dagogo-Jack, D. Smiley, 2008, Nature Clinical Practice Endocrinology &Metabolism.

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

Irl B Hirsch, Timothy S Bailey, Lois Jovanovič, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studies

R. Pratley, B. Charbonnel, S. Dagogo-Jack, 2020, Diabetes, obesity & metabolism.

Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria

W. Cushman, J. Wan, Y. Shih, 2014 .

Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria.

Ya-Chen Tina Shih, W. Cushman, J. Wan, 2014, Journal of Pharmaceutical Health Services Research.

Higher Predictive Value Positive for MMA Than ACA MTM Eligibility Criteria Among Racial and Ethnic Minorities: An Observational Study

W. Cushman, J. Wan, Y. Shih, 2018, Inquiry : a journal of medical care organization, provision and financing.

Association of plasma acylcarnitines with insulin sensitivity, insulin secretion, and prediabetes in a biracial cohort

J. Wan, F. Stentz, S. Dagogo-Jack, 2021, Experimental biology and medicine.

Amino acid signature predictive of incident prediabetes: A case-control study nested within the longitudinal pathobiology of prediabetes in a biracial cohort

J. Wan, F. Stentz, S. Dagogo-Jack, 2019, Metabolism.

Comparison of vildagliptin and thiazolidinedione as add‐on therapy in patients inadequately controlled with metformin: results of the GALIANT trial – a primary care, type 2 diabetes study

L. Blonde, R. Pratley, S. Dagogo-Jack, 2009, Diabetes, obesity & metabolism.

Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS‐CV)

C. Cannon, Darren K Mcguire, R. Pratley, 2018, American heart journal.

Fasting plasma leptin level is a surrogate measure of insulin sensitivity.

S. Dagogo-Jack, H. Askari, G. Tykodi, 2010, The Journal of clinical endocrinology and metabolism.

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.

C. Cannon, Darren K Mcguire, R. Pratley, 2020, The New England journal of medicine.

American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease.

G. Bray, J. McGill, C. Hennekens, 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease

C. Cannon, D. McGuire, R. Pratley, 2020, Circulation.

Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study

A. Paterson, E. Soliman, T. Orchard, 2021, Diabetes Care.

Dynamic Leptin Secretion in Obesity and Diabetes

S. Dagogo-Jack, 2015 .

Leukocyte count and cardiometabolic risk among healthy participants with parental type 2 diabetes: the Pathobiology of Prediabetes in a Biracial Cohort study.

J. Wan, S. Dagogo-Jack, Sotonte Ebenibo, 2012, Ethnicity & disease.

Ethnic disparity in hemoglobin A1c levels among normoglycemic offspring of parents with type 2 diabetes mellitus.

J. Wan, S. Dagogo-Jack, Chimaroke Edeoga, 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Metabolomic Prediction of Diabetes and Cardiovascular Risk

S. Dagogo-Jack, 2012, Medical Principles and Practice.

The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CV

C. Cannon, R. Pratley, S. Dagogo-Jack, 2022, Diabetes, obesity & metabolism.

Heart and Kidney Outcomes With Ertugliflozin in People with Non-albuminuric Diabetic Kidney Disease: A post hoc Analysis from the Randomized VERTIS CV Trial

C. Cannon, R. Pratley, S. Dagogo-Jack, 2022, Kidney international reports.

Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial

C. Cannon, D. McGuire, R. Pratley, 2021, Diabetologia.

Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial

D. McGuire, R. Pratley, W. Shih, 2021, BMJ Open Diabetes Research & Care.

Leptin and the Kidney

S. Dagogo-Jack, D. Coyne, R. Pandey, 2015 .

Hemoglobin A1c Diagnostic Cutoff Differences Between Black and White Persons

S. Dagogo-Jack, 2013, Annals of Internal Medicine.

Effect of once‐weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c

F. Giorgino, I. Pávó, B. Gallwitz, 2017, Diabetes, obesity & metabolism.

Neuroendocrine Regulation of Food Intake

S. Dagogo-Jack, 2005 .

Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo‐controlled randomized study

S. Engel, G. Golm, S. Dagogo-Jack, 2017, Diabetes, obesity & metabolism.

Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone

M. Davies, J. Frias, G. Golm, 2017, Diabetes, obesity & metabolism.

Combination of recreational soccer and caloric restricted diet reduces markers of protein catabolism and cardiovascular risk in patients with type 2 diabetes

P. Krustrup, S. Dagogo-Jack, M. R. D. da Silva, 2016, The journal of nutrition, health & aging.

Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.

W. Cushman, J. Wan, S. Dagogo-Jack, 2020, Research in social & administrative pharmacy : RSAP.

Augmentation of bone mineral density in hirsute women.

S. Dagogo-Jack, N. Al-Ali, M. Qurttom, 1997, The Journal of clinical endocrinology and metabolism.

Dynamic Responses to Leptin Secretagogues in Lean, Obese, and Massively Obese Men and Women

S. Dagogo-Jack, H. Askari, I. Umamaheswaran, 2008, Hormone Research in Paediatrics.

Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.

W. Cushman, Y. Shih, S. Dagogo-Jack, 2021, American health & drug benefits.

Primary prevention of type-2 diabetes in developing countries.

S. Dagogo-Jack, 2006, Journal of the National Medical Association.

Prevention begets prevention — lessons from the Da Qing Study

S. Dagogo-Jack, 2019, Nature Reviews Endocrinology.

Hyperleptinemia in Patients with End-Stage Renal Disease Undergoing Continuous Ambulatory Peritoneal Dialysis

F. Ovalle, S. Dagogo-Jack, M. Landt, 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Sulfonylureas and Ischemic Heart Disease

S. Dagogo-Jack, 1998 .

Physiological responses during hypoglycaemia induced by regular human insulin or a novel human analogue, insulin glargine

S. Dagogo-Jack, H. Askari, X. Sha, 2000, Diabetes, obesity & metabolism.

Gradient of Risk and Associations with Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function: Observations from VERTIS CV.

C. Cannon, D. McGuire, R. Pratley, 2020, Circulation.

Physiological and Hormonal Factors that Influence Leptin Production

S. Dagogo-Jack, 2015 .

Hormonal regulation of human leptin in vivo: effects of hydrocortisone and insulin

S. Dagogo-Jack, H. Askari, J. Liu, 2000, International Journal of Obesity.

Reproducibility of fasting plasma leptin concentration in lean and obese humans.

S. Dagogo-Jack, H. Askari, J. Liu, 1999, Endocrine research.

Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter]

C. Cannon, D. McGuire, R. Pratley, 2022, Diabetologia.

Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV

C. Cannon, R. Pratley, S. Dagogo-Jack, 2022, Diabetes, obesity & metabolism.

Ertugliflozin and Slope of Chronic eGFR

C. Cannon, D. McGuire, R. Pratley, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial

C. Cannon, D. McGuire, R. Pratley, 2022, American Journal of Nephrology.

Leptin response to glucocorticoid occurs at physiological doses and is abolished by fasting.

S. Dagogo-Jack, H. Askari, I. Umamaheswaran, 2003, Obesity research.

Basal and stimulated plasma leptin in diabetic subjects.

S. Dagogo-Jack, H. Askari, J. Liu, 1999, Obesity research.

Robust leptin secretory responses to dexamethasone in obese subjects.

J. Newcomer, G. Selke, A. K. Melson, 1997, The Journal of clinical endocrinology and metabolism.

Growth factors and the skeletal System

Rosso, S. Turner, L. Marinis, 2011 .

Hyperglycemic, high anion-gap metabolic acidosis in patients receiving SGLT-2 inhibitors for diabetes management.

A. Gosmanov, S. Dagogo-Jack, H. Steinberg, 2017, Journal of diabetes and its complications.

Leptin elimination in hyperleptinaemic peritoneal dialysis patients.

C. Parvin, S. Dagogo-Jack, M. Landt, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Human leptin regulation and promise in pharmacotherapy.

S. Dagogo-Jack, 2001, Current drug targets.

Impaired leptin response to glucocorticoid as a chronic complication of diabetes.

S. Dagogo-Jack, H. Askari, I. Umamaheswaran, 2000, Journal of diabetes and its complications.

High-flux dialysis lowers plasma leptin concentration in chronic dialysis patients.

S. Klein, S. Dagogo-Jack, M. Landt, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Uremic hyperleptinemia: adaptive or maladaptive?

S. Dagogo-Jack, 1998, Kidney international.

Biomarkers of insulin action during single soccer sessions before and after a 12-week training period in type 2 diabetes patients on a caloric-restricted diet

P. Krustrup, H. Zouhal, S. Dagogo-Jack, 2019, Physiology & Behavior.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.

R. DeFronzo, G. Grunberger, G. Umpierrez, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Comment on: Maruthur et al. Does Genetic Ancestry Explain Higher Values of Glycated Hemoglobin in African Americans? Diabetes 2011;60:2434–2438

S. Dagogo-Jack, 2011, Diabetes.

Inhibition of cortisol biosynthesis decreases circulating leptin levels in obese humans.

S. Dagogo-Jack, I. Umamaheswaran, G. Tykodi, 2005, The Journal of clinical endocrinology and metabolism.

Energy adaptation to glucocorticoid-induced hyperleptinemia in human beings.

S. Dagogo-Jack, H. Askari, Jianmei Liu, 2005, Metabolism: clinical and experimental.

Management of Diabetes Mellitus in Surgical Patients

K. Alberti, S. Dagogo-Jack, 2002 .

A Review of its Therapeutic Use as a Long-Acting Agent for the Management of Type 1 and 2 Diabetes Mellitus

L. Heinemann, H. Yki-Järvinen, G. Bolli, 2001 .

AACE comprehensive diabetes management algorithm 2013.

J. McGill, I. Hirsch, G. Grunberger, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes.

S. Fowler, E. Barrett-Connor, W. Fujimoto, 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

URINARY EXCRETION OF HUMAN EPIDERMAL GROWTH FACTOR IN THE VARIOUS STAGES OF DIABETIC NEPHROPATHY

K. Alberti, S. Dagogo-Jack, S. Marshall, 1989, Clinical endocrinology.

Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus

C. Cannon, A. Pandey, D. McGuire, 2022, Diabetes, obesity & metabolism.

Regulation and possible significance of leptin in humans: Leptin in health and disease

S. Dagogo-Jack, 1999 .

Response to Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657–664

J. Lachin, I. Bebu, W. Sivitz, 2019, Diabetes Care.

Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial

C. Cannon, D. McGuire, R. Pratley, 2022, Circulation.

Recombinant human insulin-like growth factor-I (IGF-I) therapy decreases plasma leptin concentration in patients with chronic renal insufficiency

S. Dagogo-Jack, S. Miller, H. Askari, 1998, International Journal of Obesity.

Islet cell encapsulation – Application in diabetes treatment

S. Dagogo-Jack, E. Opara, A. Jost, 2021, Experimental biology and medicine.

Response to Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684–1692

K. Furie, C. Viscoli, W. Kernan, 2017, Diabetes Care.

Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing's syndrome.

S. Dagogo-Jack, N. Woodhouse, R. Judzewitsch, 1993, The American journal of medicine.

Cardiometabolic Risk Factors and Incident Cardiovascular Disease Events in Women vs Men With Type 1 Diabetes

C. Cowie, D. Nathan, J. Lachin, 2022, JAMA network open.

DESIGN AND BASELINE CHARACTERISTICS OF THE EVALUATION OF ERTUGLIFOZIN EFFICACY AND SAFETY CARDIOVASCULAR OUTCOMES TRIAL (VERTIS-CV)

C. Cannon, D. McGuire, R. Pratley, 2018 .

Predicting, managing and preventing new-onset diabetes after transplantation.

A. Gosmanov, S. Dagogo-Jack, 2012, Minerva endocrinologica.

Reversible muscle weakness in patients with vitamin D deficiency.

S. Dagogo-Jack, K. Ziambaras, 1997, The Western journal of medicine.

783-P: Cardiorenal Outcomes with Ertugliflozin by Baseline (BL) Glucose-Lowering Agent (GLA): An Analysis from VERTIS CV

C. Cannon, D. McGuire, R. Pratley, 2021, Diabetes.

Sickle Cell Trait, European Ancestry, and Longitudinal Tracking of HbA1c Among African Americans: The Jackson Heart Study

S. Musani, A. Correa, M. Sims, 2019, Diabetes Care.

Severe Hypoglycemia and Incident Heart Failure among Adults With Type 2 Diabetes.

G. Fonarow, S. Dagogo-Jack, J. Echouffo-Tcheugui, 2021, The Journal of clinical endocrinology and metabolism.

Testosterone regulates epidermal growth factor levels in the thyroid gland of hypothyroid mice.

S. Dagogo-Jack, 1992, Endocrine research.

Increased Salivary Concentration of Human Epidermal Growth Factor in Patients Undergoing CAPD

S. Dagogo-Jack, R. Rodger, Pat Kendall I Aylor”, 1991, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Monotherapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Diet and Exercise Alone

M. Davies, J. Frias, G. Golm, 2017 .

Author's reply: Pitfalls in the use of HbA1c as a diagnostic test

S. Dagogo-Jack, 2010, Nature Reviews Endocrinology.

Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management.

S. Dagogo-Jack, 2003, Journal of the National Medical Association.

Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study

J. Lachin, I. Bebu, W. Sivitz, 2019, Diabetes Care.

Cost of Troglitazone Therapy

S. Dagogo-Jack, 1998 .

Comparative Effectiveness of Medication Therapy Management Eligibility Criteria Across Racial/Ethnic Groups

W. Cushman, S. Dagogo-Jack, M. Chisholm-Burns, 2019, Journal of The American Geriatrics Society.

Hypoglycemia-Induced Autonomic Failure in IDDM is Specific for Stimulus of Hypoglycemia and Is Not Attributable to Prior Autonomic Activation

P. Cryer, C. Rattarasarn, S. Dagogo-Jack, 1994, Diabetes.

Response to the letter to the editor by Chapelot

S. Dagogo-Jack, 2006 .

Whole body leptin kinetics and renal metabolism in vivo.

S. Klein, W. Kohrt, S. Dagogo-Jack, 1997, The American journal of physiology.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.

Irl B Hirsch, Janet B McGill, Lawrence Blonde, 2018, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Posterior Pituitary

S. Dagogo-Jack, Samuel DAGOGO-JACK, 2009 .

Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study.

J. Newcomer, P. Cryer, S. Craft, 1993, Behavioral neuroscience.

Thyroid function during pregnancy.

Corinne R. Fantz, J. Ladenson, S. Dagogo-Jack, 1999, Clinical chemistry.

Salivary epidermal growth factor concentration in thyrotoxicosis.

S. Dagogo-Jack, 1995, Nutrition (Burbank, Los Angeles County, Calif.).

Sialoadenectomy increases the concentration of immunoreactive epidermal growth factor in the mouse thyroid gland.

S. Dagogo-Jack, 1992, Thyroid : official journal of the American Thyroid Association.

Basal and Dynamic Leptin Secretion: Association with Cardiometabolic Risk and Body Weight Trajectories in African-Americans and European-Americans

S. Dagogo-Jack, Sotonte Ebenibo, Chimaroke Edeoga, 2018, Front. Endocrinol..

Whole body leptin kinetics and renal metabolism in vivo.

S. Klein, W. Kohrt, S. Dagogo-Jack, 1997, American journal of physiology. Endocrinology and metabolism.

Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans.

J. Newcomer, G. Vogler, G. Selke, 1998, Archives of general psychiatry.

Trajectories of Body Weight and Fat Mass in Relation to Incident Prediabetes in a Biracial Cohort of Free-Living Adults

S. Dagogo-Jack, Sotonte Ebenibo, Chimaroke Edeoga, 2020, Journal of the Endocrine Society.

Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.

S. Dagogo-Jack, Ben Brannick, 2018, Endocrinology and metabolism clinics of North America.

Editorial: The continuum of dysglycemia: Predicting progression from prediabetes to type 2 diabetes.

S. Dagogo-Jack, 2017, Journal of diabetes and its complications.

Primary Prevention of Type 2 Diabetes: An Imperative for Developing Countries

S. Dagogo-Jack, 2017 .

Plasma lipid levels predict dysglycemia in a biracial cohort of nondiabetic subjects: Potential mechanisms

J. Wan, S. Dagogo-Jack, Ibiye Owei, 2016, Experimental biology and medicine.

Adiponectin levels predict prediabetes risk: the Pathobiology of Prediabetes in A Biracial Cohort (POP-ABC) study

J. Wan, S. Dagogo-Jack, Sotonte Ebenibo, 2016, BMJ Open Diabetes Research and Care.

Lack of racial disparity in incident prediabetes and glycemic progression among black and white offspring of parents with type 2 diabetes: the pathobiology of prediabetes in a biracial cohort (POP-ABC) study.

J. Wan, E. Nyenwe, S. Dagogo-Jack, 2014, The Journal of clinical endocrinology and metabolism.

Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC) study: baseline characteristics of enrolled subjects.

S. Dagogo-Jack, Sotonte Ebenibo, Chimaroke Edeoga, 2013, The Journal of clinical endocrinology and metabolism.

Prediabetes as a therapeutic target.

S. Dagogo-Jack, Omid Rad Pour, 2011, Clinical chemistry.

Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC): design and methods.

J. Wan, E. Nyenwe, S. Dagogo-Jack, 2011, Ethnicity & disease.

Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program

E. Barrett-Connor, D. Marrero, E. Horton, 2008, Diabetes Care.

Management of Type 2 Diabetes in Underrepresented Minorities in the U.S.

S. Dagogo-Jack, 2005 .

Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions.

J. Santiago, S. Dagogo-Jack, Samuel Dagogo-Jack, 1997, Archives of internal medicine.

Genetic Ancestry Markers and Difference in A1c Between African American and White in the Diabetes Prevention Program

K. Jablonski, E. Barrett-Connor, J. Florez, 2018, The Journal of clinical endocrinology and metabolism.

Diabetes in High-Risk Ethnic Populations

E. Nyenwe, S. Dagogo-Jack, 2016 .

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan.

Irl B Hirsch, Kenneth L Jones, Lois Jovanovič, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Dietary iodine affects epidermal growth factor levels in mouse thyroid and submaxillary glands.

S. Dagogo-Jack, 1994, Endocrine research.

TCF7L2 Polymorphism, Weight Loss and Proinsulin∶Insulin Ratio in the Diabetes Prevention Program

K. Jablonski, J. Florez, R. Wing, 2011, PloS one.

TCF 7 L 2 Polymorphism , Weight Loss and Proinsulin : Insulin Ratio in the Diabetes Prevention Program

K. Jablonski, R. Wing, W. Knowler, 2011 .

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.

J. Garber, J. McGill, R. DeFronzo, 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.

J. Garber, J. McGill, R. DeFronzo, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

Irl B Hirsch, Janet B McGill, Lawrence Blonde, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American association of clinical endocrinologists and american college of endocrinology consensus conference on obesity: building an evidence base for comprehensive action.

G. Bray, J. McGill, C. Hennekens, 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes

C. Cannon, D. McGuire, R. Pratley, 2020, JAMA cardiology.

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

M. Budoff, R. Eckel, I. D. de Boer, 2021, Journal of diabetes and its complications.

American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary.

Irl B Hirsch, Kenneth L Jones, Lois Jovanovič, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program

S. Brunak, X. Pi-Sunyer, R. Goldberg, 2021, BMJ Open Diabetes Research & Care.

Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)

G. Bray, W. Knowler, N. White, 2019, Diabetes Care.

Dietary habits and leisure-time physical activity in relation to adiposity, dyslipidemia, and incident dysglycemia in the pathobiology of prediabetes in a biracial cohort study.

J. Wan, S. Dagogo-Jack, Sotonte Ebenibo, 2015, Metabolism: clinical and experimental.

Insulin resistance in HIV protease inhibitor-associated diabetes.

K. Yarasheski, P. Cryer, P. Halban, 1999, Journal of acquired immune deficiency syndromes.

AACE/ACE comprehensive diabetes management algorithm 2015.

J. Garber, J. McGill, I. Hirsch, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Hypoglycemia in Type 1 Diabetes Mellitus

S. Dagogo-Jack, 2004, Treatments in endocrinology.

S. Klein, J. Santiago, S. Dagogo-Jack, 2022 .

Demonstration of significant epidermal growth factor activity in murine thyroid tissue.

S. Dagogo-Jack, P. Kendall‐Taylor, S. Atkinson, 1986, The Journal of endocrinology.

Five-Year Glycemic Trajectories Among Healthy African-American and European-American Offspring of Parents With Type 2 Diabetes.

J. Wan, S. Dagogo-Jack, Sotonte Ebenibo, 2020, The American journal of the medical sciences.

Recognizing iodine deficiency in iodine-replete environments.

E. Nyenwe, S. Dagogo-Jack, 2007, New England Journal of Medicine.

Iodine Deficiency Disorders in the Iodine-Replete Environment

E. Nyenwe, S. Dagogo-Jack, 2009, The American journal of the medical sciences.

Role of ceramides in the pathogenesis of diabetes mellitus and its complications.

S. Dagogo-Jack, S. Basu, K. Mondal, 2020, Journal of diabetes and its complications.

Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum

S. Dagogo-Jack, 2010, Nature Reviews Endocrinology.

Calorie Restriction and Intermittent Fasting: Impact on Glycemic Control in People With Diabetes

S. Dagogo-Jack, K. Ganesan, Y. Habboush, 2020, Diabetes Spectrum.

Approach to the patient with new-onset diabetes after transplant (NODAT).

S. Dagogo-Jack, J. Lane, 2011, The Journal of clinical endocrinology and metabolism.

HIV Therapy and Diabetes Risk

S. Dagogo-Jack, 2008, Diabetes Care.

Chapter 42 – New Drugs and Diabetes Risk: Antipsychotic and Antiretroviral Agents

S. Dagogo-Jack, 2006 .

American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement

J. McGill, I. Hirsch, G. Grunberger, 2013 .

Reversal of Hypoglycemia Unawareness, But Not Defective Glucose Counterregulation, in IDDM

P. Cryer, C. Rattarasarn, S. Dagogo-Jack, 1994, Diabetes.

Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.

P. Cryer, S. Craft, S. Dagogo-Jack, 1993, The Journal of clinical investigation.

Preventing diabetes mellitus in developing countries

S. Dagogo-Jack, J. Echouffo-Tcheugui, 2012, Nature Reviews Endocrinology.

Diabetes and cancer--an AACE/ACE consensus statement.

J. McGill, C. Hennekens, H. Lebovitz, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Association of bone mineral density with prediabetes risk among African-American and European-American adult offspring of parents with type 2 diabetes

S. Dagogo-Jack, Peace C. Asuzu, Zhao Liu, 2023, Frontiers in Endocrinology.

Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized Obesity

R. Carr, S. Dagogo-Jack, O. Pickett-Blakely, 2019, Current Obesity Reports.

Plasma FGF-21 and Sclerostin Levels, Glycemia, Adiposity, and Insulin Sensitivity in Normoglycemic Black and White Adults

F. Stentz, S. Dagogo-Jack, Ibiye Owei, 2021, Journal of the Endocrine Society.

Ethnic Disparities in Endothelial Function and Its Cardiometabolic Correlates: The Pathobiology of Prediabetes in A Biracial Cohort Study

J. Wan, S. Dagogo-Jack, Sotonte Ebenibo, 2018, Front. Endocrinol..

Relationships between blood pressure and blood glucose among offspring of parents with type 2 diabetes: Prediction of incident dysglycemia in a biracial cohort.

J. Wan, S. Dagogo-Jack, Chimaroke Edeoga, 2017, Journal of diabetes and its complications.

Dissociation Between Cardiovascular Risk Markers and Clinical Outcomes in African Americans: Need for Greater Mechanistic Insight

S. Dagogo-Jack, I. Dagogo-Jack, 2011 .

Predicting Diabetes: Our Relentless Quest for Genomic Nuggets

S. Dagogo-Jack, 2012, Diabetes Care.

Diabetes Care in Nigeria.

S. Dagogo-Jack, O. Fasanmade, 2016, Annals of global health.

AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.

I. Hirsch, G. Grunberger, G. Umpierrez, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Genetic Risk of Progression to Type 2 Diabetes and Response to Intensive Lifestyle or Metformin in Prediabetic Women With and Without a History of Gestational Diabetes Mellitus

K. Jablonski, J. Florez, W. Knowler, 2014, Diabetes Care.

Hypoglycemia in Patients with Type 1 Diabetes: Epidemiology, Pathogenesis, and Prevention

S. Dagogo-Jack, O. Awoniyi, Rabia Rehman, 2013, Current Diabetes Reports.

Serum urate and cardiovascular events in the DCCT/EDIC study

B. Zinman, A. Jenkins, D. Nathan, 2021, Scientific Reports.

Coprogression of Cardiovascular Risk Factors in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study

S. Genuth, J. Lachin, I. Bebu, 2016, Diabetes Care.

Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC): Retention Strategies

S. Dagogo-Jack, Sotonte Ebenibo, Chimaroke Edeoga, 2013, Diabetes Care.

Replication of the Association of BDNF and MC4R Variants With Dietary Intake in the Diabetes Prevention Program

K. Jablonski, E. Barrett-Connor, D. Marrero, 2016, Psychosomatic medicine.

Update on Medical Management of Diabetes: Focus on Relevance for Orthopedic Surgeons.

S. Dagogo-Jack, D. James, Dilasha Katwal, 2023, The Orthopedic clinics of North America.

Preventing diabetes mellitus in developing countries

S. Dagogo-Jack, J. Echouffo-Tcheugui, 2012, Nature Reviews Endocrinology.

Principles and Practice of Nonpharmacological Interventions to Reduce Cardiometabolic Risk

S. Dagogo-Jack, Chimaroke Edeoga, Nonso Egbuonu, 2010, Medical Principles and Practice.

Primary prevention of cardiovascular disease in pre-diabetes: the glass is half full and half empty.

S. Dagogo-Jack, 2005, Diabetes care.

Regression from prediabetes to normal glucose regulation: State of the science

S. Dagogo-Jack, Anthony Sallar, 2020, Experimental biology and medicine.

Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) Study: design of lifestyle intervention

J. Wan, A. Brewer, S. Dagogo-Jack, 2020, BMJ open diabetes research & care.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.

J. Garber, J. McGill, I. Hirsch, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

J. McGill, I. Hirsch, G. Grunberger, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

A Polygenic Lipodystrophy Genetic Risk Score Characterizes Risk Independent of BMI in the Diabetes Prevention Program

G. Bray, K. Jablonski, J. Florez, 2019, Journal of the Endocrine Society.

2015 Presidential Address: 75 Years of Battling Diabetes−Our Global Challenge

S. Dagogo-Jack, 2015, Diabetes Care.

Philip E. Cryer, MD: Seminal Contributions to the Understanding of Hypoglycemia and Glucose Counterregulation and the Discovery of HAAF (Cryer Syndrome)

S. Dagogo-Jack, 2015, Diabetes Care.

Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program

Thomas J. Wang, J. Florez, W. Knowler, 2019, Diabetes.

Cardiorenal outcomes, kidney function, and other safety outcomes with ertugliflozin in older adults with type 2 diabetes (VERTIS CV): secondary analyses from a randomised, double-blind trial.

C. Cannon, D. McGuire, R. Pratley, 2023, The lancet. Healthy longevity.

Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV) Trial.

C. Cannon, D. McGuire, R. Pratley, 2023, Kidney international reports.

Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV

C. Cannon, R. Pratley, S. Dagogo-Jack, 2023, The Journal of clinical endocrinology and metabolism.

Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium‐glucose cotransporter‐2 inhibitor ertugliflozin

C. Cannon, R. Pratley, Karen D. Corbin, 2022, Diabetes, obesity & metabolism.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY.

G. Bray, J. McGill, I. Hirsch, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications

S. Dagogo-Jack, Ben Brannick, Anne Wynn, 2016, Experimental biology and medicine.

Epidemiology of type 2 diabetes: focus on ethnic minorities.

L. Egede, S. Dagogo-Jack, 2005, The Medical clinics of North America.

865-P: Long-Term Ertugliflozin Treatment and Incidence of Hypoglycemia: Analyses from VERTIS CV

C. Cannon, D. McGuire, R. Pratley, 2022, Diabetes.

791-P: Ertugliflozin in Older Patients with Type 2 Diabetes (T2D): An Analysis from VERTIS CV

C. Cannon, D. McGuire, R. Pratley, 2021, Diabetes.

Kidney outcomes using a sustained ≥40% decline in eGFR: A meta‐analysis of SGLT2 inhibitor trials

C. Cannon, D. McGuire, R. Pratley, 2021, Clinical cardiology.

Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease

C. Cannon, D. McGuire, R. Pratley, 2023, Diabetes, obesity & metabolism.

Memory improvement following induced hyperinsulinemia in alzheimer's disease

Y. Sheline, J. Newcomer, P. Cryer, 1996, Neurobiology of Aging.

DCCT Results and Diabetes Care in Developing Countries

S. Dagogo-Jack, 1995, Diabetes Care.

Effect of intra-trial mean 25(OH)D level on diabetes risk, by race and weight: an ancillary analysis in the D2d randomized study cohort.

J. Nelson, S. Kashyap, E. Leblanc, 2023, The American journal of clinical nutrition.

Racial and ethnic disparities in Medicare Part D medication therapy management services utilization

W. Cushman, S. Dagogo-Jack, M. Chisholm-Burns, 2023, Exploratory research in clinical and social pharmacy.

Disparity implications of the Medicare medication therapy management eligibility criteria: a literature review

J. Wan, Y. Shih, S. Dagogo-Jack, 2013, Expert review of pharmacoeconomics & outcomes research.

Disparity implications of Medicare eligibility criteria for medication therapy management services.

W. Cushman, C. Mullins, Y. Shih, 2010, Health services research.

Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups

W. Cushman, J. Wan, Y. Shih, 2015, Journal of managed care & specialty pharmacy.

Effects of medicare part d on disparity implications of medication therapy management eligibility criteria.

W. Cushman, J. Wan, Y. Shih, 2014, American health & drug benefits.

Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.

Ya-Chen Tina Shih, W. Cushman, J. Wan, 2013, Research in social & administrative pharmacy : RSAP.

Racial and ethnic disparities in the enrolment of medicare medication therapy management programs

W. Cushman, S. Dagogo-Jack, M. Chisholm-Burns, 2023, Journal of Pharmaceutical Health Services Research.

Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act

W. Cushman, J. Wan, Y. Shih, 2018, Journal of managed care & specialty pharmacy.

Physiology of Glycemic Recovery and Stabilization After Hyperinsulinemic Euglycemic Clamp in Healthy Subjects.

S. Dagogo-Jack, Nidhi Jain, Ibiye Owei, 2018, The Journal of clinical endocrinology and metabolism.

Multi-Year Reproducibility of Hyperinsulinemic Euglycemic Clamp-Derived Insulin Sensitivity in Free-Living Adults: Association with Incident Prediabetes in the POP-ABC Study.

E. Nyenwe, S. Dagogo-Jack, Chimaroke Edeoga, 2020, Metabolism: clinical and experimental.

Comparisons of changes over time in per capita health expenditures across racial and ethnic groups

Cyril F. Chang, W. Cushman, C. Mullins, 2010 .

Diabetes Mellitus in Developing Countries and Underserved Communities

S. Dagogo-Jack, Samuel Dagogo-Jack, 2017 .

Diagnosis and Management of Prediabetes: A Review.

L. Perreault, L. Ji, S. Dagogo-Jack, 2023, JAMA.

Outcome of lifestyle intervention in relation to duration of pre-diabetes: the Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) study

A. Brewer, S. Dagogo-Jack, Vamsee K. Mupparaju, 2022, BMJ Open Diabetes Research & Care.

Glycemic Response to Oral Dexamethasone Predicts Incident Prediabetes in Normoglycemic Subjects With Parental Diabetes

J. Wan, E. Nyenwe, S. Dagogo-Jack, 2020, Journal of the Endocrine Society.

Barriers to achieving optimal glycemic control in a multi-ethnic society: a US focus.

M. Funnell, J. Davidson, S. Dagogo-Jack, 2006, Current diabetes reviews.

Exploring racial and ethnic disparities in medication adherence among Medicare comprehensive medication review recipients

W. Cushman, J. Wan, S. Dagogo-Jack, 2021, Exploratory research in clinical and social pharmacy.

Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS)

E. Barrett-Connor, W. Knowler, R. Hamman, 2017, Diabetic medicine : a journal of the British Diabetic Association.

Insulin-sensitive and insulin-resistant obese and non-obese phenotypes: role in prediction of incident pre-diabetes in a longitudinal biracial cohort

J. Wan, S. Dagogo-Jack, Ibiye Owei, 2017, BMJ Open Diabetes Research & Care.

DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes

Angelo J. Canty, J. Keith Jones, A. Paterson, 2020, Clinical Epigenetics.

Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study

M. Montez, E. Walker, Jeffrey S. Gonzalez, 2020, BMJ open diabetes research & care.

Cardiovascular outcomes of antidiabetes medications by race/ethnicity: A systematic review and meta-analysis.

L. Ji, Chu Lin, Wenjia Yang, 2020, Journal of diabetes and its complications.

Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials

G. Reed, S. Kar, S. Dagogo-Jack, 2015, American Journal of Cardiovascular Drugs.

The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendations.

L. Blonde, A. Garber, Z. Bloomgarden, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

People with diabetes and self-reported severe hypoglycaemia have increased mortality risk over 5 years

S. Dagogo-Jack, 2012, Evidence-Based Nursing.

Awareness of Prediabetes Status and Subsequent Health Behavior, Body Weight, and Blood Glucose Levels

S. Dagogo-Jack, Ibiye Owei, Nkiru Umekwe, 2019, The Journal of the American Board of Family Medicine.

Association of history of heart failure with hospital outcomes of hyperglycemic crises: Analysis from a University hospital and national cohort.

G. Reed, R. Khouzam, S. Dagogo-Jack, 2019, Journal of diabetes and its complications.

Cost-Effectiveness of Medication Therapy Management Program Across Racial and Ethnic Groups Among Medicare Beneficiaries.

W. Cushman, Y. Shih, S. Dagogo-Jack, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease

K. Furie, C. Viscoli, W. Kernan, 2016, Diabetes Care.

Homologous radioimmunoassay for epidermal growth factor in human saliva.

S. Dagogo-Jack, P. Kendall‐Taylor, S. Atkinson, 1985, Journal of immunoassay.

Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study

J. Keith Jones, A. Paterson, S. Mudaliar, 2018, Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease.

Cerebral transport and metabolism of 1‐11C‐D‐glucose during stepped hypoglycemia

K. B. Larson, C. Dence, J. Markham, 1995, Annals of neurology.

Preventing diabetes-related morbidity and mortality in the primary care setting.

S. Dagogo-Jack, Samuel Dagogo-Jack, 2002, Journal of the National Medical Association.

Role of thiazolidinediones in the management of type 2 diabetes: focus on ethnic minority populations.

G. Umpierrez, S. Dagogo-Jack, 2006, Ethnicity & disease.

Isolation of the Human LIM/Homeodomain Gene Islet-1 and Identification of a Simple Sequence Repeat 1

M. Permutt, P. Froguel, M. Vaxillaire, 1994, Diabetes.

Genetic Risk Factors for CVD in Type 1 Diabetes: The DCCT/EDIC Study

Angelo J. Canty, A. Paterson, W. Herman, 2021, Diabetes Care.

Role of the HPA Axis in the Metabolic and Baroreflex Components of Hypoglycemia-Associated Autonomic Failure.

S. Dagogo-Jack, 2020, The Journal of clinical endocrinology and metabolism.

Epidermal Growth Factor EGF in human saliva: Effect of age, sex, race, pregnancy and sialagogue

S. Dagogo-Jack, 1986 .

Metabolic syndrome, prediabetes and the science of primary prevention.

E. Nyenwe, S. Dagogo-Jack, 2011, Minerva endocrinologica.

Multiple drug targets in the management of type 2 diabetes.

S. Dagogo-Jack, M. H. Moneva, 2002, Current drug targets.

Parental history of type 2 diabetes is associated with lower resting energy expenditure in normoglycemic subjects

J. Wan, E. Nyenwe, S. Dagogo-Jack, 2018, BMJ Open Diabetes Research & Care.

Diagnostic Cutoff Differences Between Black and White Persons

S. Dagogo-Jack, 2012 .

Diagnostic Cutoff Differences Between Black and White Persons

C. Wee, Y. Tsugawa, S. Dagogo-Jack, 2012 .

Review of Prediabetes-Reply.

S. Dagogo-Jack, 2023, Journal of the American Medical Association (JAMA).

Ceramides and other sphingolipids as predictors of incident dysglycemia (CASPID): Design, methods, and baseline characteristics

F. Stentz, S. Dagogo-Jack, Peace C. Asuzu, 2023, Experimental biology and medicine.

Response to Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684–1692

K. Furie, C. Viscoli, W. Kernan, 2017, Diabetes Care.

P. Cryer, S. Craft, S. Dagogo-Jack, 1993, The Journal of clinical investigation.

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

J. McGill, I. Hirsch, G. Grunberger, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

G. Bray, J. McGill, I. Hirsch, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[Management of diabetes mellitus in surgical patients].

K. Alberti, S. Dagogo-Jack, C. Shuman, 1954, El Dia medico.

American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement

J. McGill, I. Hirsch, G. Grunberger, 2013, Endocrine Practice.

Running title: amino acids and prediabetes risk in blacks and whites.

J. Wan, F. Stentz, S. Dagogo-Jack, 2019, Metabolism: clinical and experimental.

Comorbidities of Diabetes and Hypertension: Mechanisms and Approach to Target Organ Protection

S. Dagogo-Jack, A. Long, 2011, Journal of clinical hypertension.

Prediabetes as a therapeutic target.

S. Dagogo-Jack, Omid Rad Pour, 2011, Clinical chemistry.

Perspectives on Chronic Kidney Disease With Type 2 Diabetes and Risk Management: Practical Viewpoints and a Paradigm Shift Using a Pillar Approach

Joshua J. Neumiller, S. Dagogo-Jack, V. Fonseca, 2023, Clinical diabetes : a publication of the American Diabetes Association.

Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose.

S. Dagogo-Jack, H. Askari, G. Tykodi, 2009, The Journal of clinical endocrinology and metabolism.

Parental History of Type 2 Diabetes Abrogates Ethnic Disparities in Key Glucoregulatory Indices

J. Wan, E. Nyenwe, S. Dagogo-Jack, 2018, The Journal of clinical endocrinology and metabolism.

Glucoregulatory function among African Americans and European Americans with normal or pre-diabetic hemoglobin A1c levels.

J. Wan, S. Dagogo-Jack, Sotonte Ebenibo, 2014, Metabolism: clinical and experimental.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.

R. DeFronzo, G. Grunberger, G. Umpierrez, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.